Patients undergoing catheter-based procedures may be enrolled without giving consent, under a U.S. exception granted to researchers.
In clinical trial, some trauma victims will receive type O whole blood instead of red blood cells and plasma, the current standard care.
For Andrew Taylor, a molecular biologist and Seattle resident, attending last week’s community conversation about a trauma study to be held at Harborview Medical Center stemmed from an experience in his past.
[See original HSNewsBeat story, "Clot drug tested with suspected brain injuries" from July 1, 2014.
[See related Q&A with Dr. Eileen Bulger from July 28.]
[Editors’ note: This is the fifth in a series of seven articles about bioethics.
This story is the first in a series of seven articles about bioethics.
